Xiao Ping Dai

Part of WuXi AppTec Co., Ltd., WuXi Advanced Therapies, Inc. is a contract testing development and manufacturing organization (CTDMO) based in Philadelphia, PA. The company offers integrated platforms to transform the discovery, development, testing, manufacturing, and commercialization of cell and gene therapies for customers worldwide. The company's technologies, automation platforms, and service solutions advance pre-clinical research and accelerate the timeline to GMP manufacture, while integrated GMP manufacturing and testing platforms reduce time to market, maintaining high titers, high levels of quality assurance, and full regulatory compliance. Ultimately, their complete end-to-end solutions support pioneering companies to deliver breakthrough cell and gene therapies to the patients who need them.